SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | Pharmaceuticals, Biotechnology and Life Sciences | Northern America | Targets set | Large | 5 | Jul 18, 2024 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2033 Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year 2050 Sector Pharmaceuticals, Biotechnology and Life Sciences Region Northern America Organization Type Corporate Location United States of America Company Size Large Target Statement Overall Net-Zero Target: Bristol Myers Squibb commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Bristol Myers Squibb (BMS) commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by 2033 from a 2022 base year.* BMS also com… Stakeholders Director of Sustainability Enablement Director of Responsible Sourcing Victoria Emerick Executive Director and Global Head, Corporate Sustainability Senior Vice President and Chief Procurement Officer Executive Vice President, Global Product Development and Supply | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.